Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one

被引:46
作者
Edwards, JP
Higuchi, RI
Winn, DT
Pooley, CLF
Caferro, TR
Hamann, LG
Zhi, L
Marschke, KB
Goldman, ME
Jones, TK
机构
[1] Dept Med Chem, San Diego, CA 92121 USA
[2] New Leads Discovery Ligand Pharmaceut, San Diego, CA 92121 USA
关键词
D O I
10.1016/S0960-894X(99)00118-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 2H-pyrano[3,2-g]quinolin-2-ones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one, displayed moderate interaction with hAR, but substituted analogues were potent hAR modulators in vitro as mesaured by an hAR cotransfection assay in CV-I cells and bound to hAR with high affinity in a whole cell assay. Several analogues were able to activate hAR-mediated gene transcription more potently and efficaciously than dihydrotestosterone. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1003 / 1008
页数:6
相关论文
共 19 条
[1]   INTERACTION OF GLUCOCORTICOID ANALOGS WITH THE HUMAN GLUCOCORTICOID RECEPTOR [J].
BERGER, TS ;
PARANDOOSH, Z ;
PERRY, BW ;
STEIN, RB .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :733-738
[2]   Emerging issues in androgen replacement therapy [J].
Bhasin, S ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :3-8
[3]   Discovery of nonsteroidal androgens [J].
Dalton, JT ;
Mukherjee, A ;
Zhu, ZX ;
Kirkovsky, L ;
Miller, DD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (01) :1-4
[4]  
EASON NR, 1962, J ORG CHEM, V27, P4713
[5]   New nonsteroidal androgen receptor modulators based on 4(trifluoromethyl)-2 (1H)-pyrrolidino[3,2-g] quinolinone [J].
Edwards, JP ;
West, SJ ;
Pooley, CLF ;
Marschke, KB ;
Farmer, LJ ;
Jones, TK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (07) :745-750
[6]   Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridino[5,6-g]quinolines [J].
Hamann, LG ;
Higuchi, RI ;
Zhi, L ;
Edwards, JP ;
Wang, XN ;
Marschke, KB ;
Kong, JW ;
Farmer, LJ ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) :623-639
[7]   Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071) [J].
Hamann, LG ;
Mani, NS ;
Davis, RL ;
Wang, XN ;
Marschke, KB ;
Jones, TK .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :210-212
[8]   Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines [J].
Hamann, LG ;
Winn, DT ;
Pooley, CLF ;
Tegley, CM ;
West, SJ ;
Farmer, LJ ;
Zhi, L ;
Edwards, JP ;
Marschke, KB ;
Mais, DE ;
Goldman, ME ;
Jones, TK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (19) :2731-2736
[9]   COPPER(I)-CATALYZED AMINATION OF PROPARGYL ESTERS - SELECTIVE SYNTHESIS OF PROPARGYLAMINES, 1-ALKEN-3-YLAMINES, AND (Z)-ALLYLAMINES [J].
IMADA, Y ;
YUASA, M ;
NAKAMURA, I ;
MURAHASHI, S .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (09) :2282-2284
[10]  
KAISARY AV, 1994, PROSTATE, P27